Pharmaceuticals

Wed, 07/28/2010 - 14:02

Leo Pharma issues global recall of sodium fusidate

Shanghai. July 28. INTERFAX-CHINA - Denmark-based Leo Pharmaceutical Products Ltd. has issued a worldwide recall of sodium fusidate for intravenous injection, the State Food and Drug Administration (SFDA) announced on its Web site July 27.

This article is only accessible to Interfax subscribers. To gain access to this article, as well similar in-depth articles and industry-specific content, please contact our sales staff by telephone (+852 2537 2262) .

Start free trial NOW